Ermira Pazolli
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Lung Cancer Treatments and Mutations, Telomeres, Telomerase, and Senescence, Bone and Dental Protein Studies, Advanced Breast Cancer Therapies
Most-Cited Works
- → H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers(2018)500 cited
- → Chromatin Remodeling Underlies the Senescence-Associated Secretory Phenotype of Tumor Stromal Fibroblasts That Supports Cancer Progression(2012)189 cited
- → AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and ESR1 -Mutant Breast Tumors in Preclinical Models(2016)174 cited
- → p38MAPK Plays a Crucial Role in Stromal-Mediated Tumorigenesis(2014)167 cited
- → Senescent Stromal-Derived Osteopontin Promotes Preneoplastic Cell Growth(2009)147 cited
- → Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia(2023)84 cited
- → Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators(2019)72 cited
- → Osteopontin Stimulates Preneoplastic Cellular Proliferation Through Activation of the MAPK Pathway(2011)59 cited
- → Senescence: the good the bad and the dysfunctional(2008)49 cited
- → Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations(2023)49 cited